Login to Your Account



Symphogen Gets $25M, As Antibody Products Progress

By Cormac Sheridan


Wednesday, January 11, 2006
Symphogen A/S raised $25 million in a Series D funding that attracted one new investor. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription